Enovix (Enovix) Accounts Receivable : $1.73 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Enovix Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Enovix's accounts receivables for the quarter that ended in Mar. 2024 was $1.73 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Enovix's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 29.91.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Enovix's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was $-0.07.

Enovix Accounts Receivable Historical Data

The historical data trend for Enovix's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovix Accounts Receivable Chart

Enovix Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

0.17

0.91

Enovix Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Receivable	Get a 7-Day Free Trial										0.02	0.04	-	0.91	1.73

Enovix Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Enovix Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Enovix's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.728	/	5.272	*	91
=	29.91

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Enovix's accounts receivable are only considered to be worth 75% of book value:

Enovix's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(262.393	+	0.75 * 1.728	+	0.5 * 6.536	-	276.798
-	0	-	2.827)	/	169.738
=	-0.07

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Enovix Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Enovix's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Enovix (Enovix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovix Corp (NAS:ENVX) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

6Q81:Germany 6Q81:Germany

Address

3501 W. Warren Avenue, Fremont, CA, USA, 94538

Website

https://www.enovix.com

Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.

Executives

Rajendra K Talluri	director, officer: President and CEO	3501 W. WARREN AVENUE, FREMONT CA 94538
Betsy S Atkins	director
Arthi Chakravarthy	officer: See Remarks	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Farhan Ahmad	officer: Chief Financial Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Bernard Gutmann	director	ON SEMICONDUCTOR C/O V PECORA (M/D A700), 5005 EAST MCDOWELL ROAD, PHOENIX AZ 85008
Ralph H Schmitt	officer: Chief Commercial Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Thurman J Rodgers	director, 10 percent owner	535 EASTVIEW WAY, WOODSIDE CA 94062
Ashok Lahiri	officer: Chief Technology Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Ajay Marathe	officer: Chief Operating Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Harrold J Rust	director, officer: President and CEO	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Gardner Cameron Dales	officer: Chief Commercial Officer	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Eclipse Fund Iii, L.p.	10 percent owner	514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Eclipse Gp Iii, Llc	10 percent owner	514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
J Daniel Mccranie	director	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Edward J Hejlek	officer: See Remarks	C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538